These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling. Tao Q; Backer MV; Backer JM; Terman BI J Biol Chem; 2001 Jun; 276(24):21916-23. PubMed ID: 11399777 [TBL] [Abstract][Full Text] [Related]
28. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. Ruckman J; Green LS; Beeson J; Waugh S; Gillette WL; Henninger DD; Claesson-Welsh L; Janjić N J Biol Chem; 1998 Aug; 273(32):20556-67. PubMed ID: 9685413 [TBL] [Abstract][Full Text] [Related]
29. Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. Sawaji Y; Sato T; Takeuchi A; Hirata M; Ito A Br J Cancer; 2002 May; 86(10):1597-603. PubMed ID: 12085210 [TBL] [Abstract][Full Text] [Related]
30. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Krum JM; Mani N; Rosenstein JM Neuroscience; 2002; 110(4):589-604. PubMed ID: 11934468 [TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Athanassiades A; Hamilton GS; Lala PK Biol Reprod; 1998 Sep; 59(3):643-54. PubMed ID: 9716565 [TBL] [Abstract][Full Text] [Related]
32. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Lee YH; Tokunaga T; Oshika Y; Suto R; Yanagisawa K; Tomisawa M; Fukuda H; Nakano H; Abe S; Tateishi A; Kijima H; Yamazaki H; Tamaoki N; Ueyama Y; Nakamura M Eur J Cancer; 1999 Jul; 35(7):1089-93. PubMed ID: 10533453 [TBL] [Abstract][Full Text] [Related]
33. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715 [TBL] [Abstract][Full Text] [Related]
34. VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells. Miralem T; Steinberg R; Price D; Avraham H Oncogene; 2001 Sep; 20(39):5511-24. PubMed ID: 11571649 [TBL] [Abstract][Full Text] [Related]
35. Ectodomain shedding of VEGF183, a novel isoform of vascular endothelial growth factor, promotes its mitogenic activity in vitro. Jingjing L; Srinivasan B; Roque RS Angiogenesis; 2001; 4(2):103-12. PubMed ID: 11806242 [TBL] [Abstract][Full Text] [Related]
36. A novel method to purify recombinant vascular endothelial growth factor (VEGF121) expressed in yeast. Mohanraj D; Olson T; Ramakrishnan S Biochem Biophys Res Commun; 1995 Oct; 215(2):750-6. PubMed ID: 7488018 [TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Wang H; Keiser JA Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730 [TBL] [Abstract][Full Text] [Related]